CAVHANZA vs OFEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CAVHANZA and OFEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	OFEV
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB	NINTEDANIB ESYLATE
Manufacturer	Flex Pharma	Boehringer Ingelheim
Dosage forms	Tablet, orally disintegrating	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Idiopathic Pulmonary Fibrosis

cavhanza ofev

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

NILOTINIB

NINTEDANIB ESYLATE

Manufacturer

Flex Pharma

Boehringer Ingelheim

Dosage forms

Tablet, orally disintegrating

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Cavhanza and Ofev?

Cavhanza contains Nilotinib, while Ofev contains Nintedanib Esylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.